These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis. Kes P Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021 [TBL] [Abstract][Full Text] [Related]
8. The role of lipid abnormalities in the pathogenesis of chronic, progressive renal disease. Kasiske BL; O'Donnell MP; Schmitz PG; Keane WF Adv Nephrol Necker Hosp; 1991; 20():109-25. PubMed ID: 2063707 [TBL] [Abstract][Full Text] [Related]
9. Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity. Ellis D; Orchard TJ; Lombardozzi S; Yunis EJ; McCauley J; Agostini R; Diamond JR J Am Soc Nephrol; 1995 Oct; 6(4):1170-7. PubMed ID: 8589283 [TBL] [Abstract][Full Text] [Related]
10. [Atherosclerosis and arteriosclerosis of the small vessels in chronic renal insufficiency and after transplantation: lipid factors]. Boizel R Nephrologie; 2000; 21(7):329-32. PubMed ID: 11200602 [TBL] [Abstract][Full Text] [Related]
11. [Dyslipidemias in renal diseases: pathogenesis and treatment]. Cuevas A; Maíz A; Arteaga A Rev Med Chil; 1998 Mar; 126(3):315-21. PubMed ID: 9674303 [TBL] [Abstract][Full Text] [Related]
12. Clinical utility of antilipidemic therapies in chronic renal allograft failure. Wanner C; Bartens W; Galle J Kidney Int Suppl; 1995 Dec; 52():S60-2. PubMed ID: 8587286 [TBL] [Abstract][Full Text] [Related]
13. Clinical strategies for arresting progression of renal disease. ter Wee PM; Donker AJ Kidney Int Suppl; 1992 Oct; 38():S114-20. PubMed ID: 1405361 [TBL] [Abstract][Full Text] [Related]
14. Derangement of lipid metabolism and its management in renal transplant patients. Keane WF Miner Electrolyte Metab; 1997; 23(3-6):166-9. PubMed ID: 9387109 [TBL] [Abstract][Full Text] [Related]
15. [Is hyperlipidemia a factor in the progression of renal failure?]. Geiger H Z Kardiol; 1993; 82 Suppl 4():35-8. PubMed ID: 8147060 [TBL] [Abstract][Full Text] [Related]
16. Treatment of dyslipidemia in chronic kidney disease. Stefanovic V; Milojkovic M Int J Artif Organs; 2004 Oct; 27(10):821-7. PubMed ID: 15560675 [TBL] [Abstract][Full Text] [Related]
17. Hyperlipidemia and kidney disease: concepts derived from histopathology and cell biology of the glomerulus. Kamanna VS; Roh DD; Kirschenbaum MA Histol Histopathol; 1998 Jan; 13(1):169-79. PubMed ID: 9476647 [TBL] [Abstract][Full Text] [Related]
18. Treatment of dyslipidemia in chronic renal failure. Toto RD Blood Purif; 1996; 14(1):75-82. PubMed ID: 8718569 [TBL] [Abstract][Full Text] [Related]
19. [What are the possibilities for treatment of hyperlipidemia in kidney insufficiency or in dialysis patients?]. Grützmacher P; Scheuermann E Med Welt; 1982 Jun; 33(24):873-4. PubMed ID: 7109928 [No Abstract] [Full Text] [Related]
20. Dyslipidemia and the progression of renal disease in chronic renal failure patients. Cases A; Coll E Kidney Int Suppl; 2005 Dec; (99):S87-93. PubMed ID: 16336584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]